Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Inclusion Criteria: * Patients diagnosed with hepatic lesions who are going to undergo hepatectomy via laparoscopy. * The patient must be between 18 and 80 years old. * The patient, or his/her representative, has given his/her consent to participate in the study. * The patient must, in the opinion of the investigator, be able to comply with all the requirements of the clinical trial. * The patient must not be allergic to the drug. Exclusion Criteria: * History of hypersensitivity to the drug to be administered. * Children under 18 years of age. * Urgent intervention. * Intervention performed in an open manner (not laparoscopic). * Patient's refusal to participate in the study. * Contraindication to receive octreotide. * Women of childbearing age (those women who are in the period between menarche and menopause). Having to present a negative pregnancy test to take part in the study. * Pregnant or lactating women, given the absence of studies of this drug in this patient profile.